Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 May 2025 | Story André Damons | Photo Supplied
Prof Wynand Goosen
Prof Wynand Goosen, Professor and Lead for One Health in the Department of Microbiology and Biochemistry at the University of the Free State was nominated in the TW Kambule-NSTF Award: Researcher category of the 2024/25 NSTF-South32 Awards.

Being nominated for a ‘Science Oscar’ is exciting and validates nominees’ efforts, particularly in a field as challenging and essential as infectious diseases, for which they are recognised at the highest level. 

This is according to Prof Wynand Goosen, Professor and Lead for One Health in the Department of Microbiology and Biochemistry at the University of the Free State (UFS). He was nominated in the TW Kambule-NSTF Award: Researcher category of the 2024/25 NSTF-South32 Awards for his landmark discovery of Mycobacterium bovis infection in humans in South Africa – the first confirmed cases in the country. 

Prof Goosen, who previously won the NSTF-South32 Emerging Researcher Award, says the nomination is a powerful affirmation of the impact that focused, interdisciplinary research can have. It reflects not only his personal commitment but also the dedication of a talented and hard-working team. “I am honoured and humbled to be nominated. It is also a testament to the support and vision of UFS, particularly as we position ourselves as leaders in One Health research in South Africa,” he says. 

 

Focus of research 

He was nominated by Prof Vasu Reddy, UFS Deputy Vice-Chancellor: Research and Internationalisation, and Prof Paul Oberholster, Dean for the Faculty of Natural and Agricultural Sciences (NAS) at the UFS, and Prof Nico Gey van Pittius and Prof Elmi Muller from Stellenbosch University (US). The NSTF Awards, known as the ‘Science Oscars’of SA, honour, reward, celebrate, profile and promote outstanding contributions to science, engineering and technology (SET) and innovation in South Africa.

“The nomination,” Prof Goosen continues, “recognises our work in the field of zoonotic tuberculosis (TB) and other emerging infectious diseases at the human-animal-environment interface. Our research focuses on the molecular detection and characterisation of pathogenic mycobacteria in wildlife, livestock, and human populations, with the aim of informing better surveillance, diagnostics, and control strategies — particularly in high-risk ecosystems. This includes novel applications in wildlife TB surveillance and understanding the transmission dynamics between animals and people.”

 

Establishing a Kovsie One Health Research Unit

This research is critically important as South Africa continues to face a high burden of tuberculosis, including zoonotic TB, which often goes under-detected in rural and wildlife-rich areas. Understanding how these pathogens circulate between humans, animals, and the environment, explains Prof Goosen, is essential for effective disease control and to mitigate future pandemics. This work directly supports national health priorities, informs policy, and contributes to global strategies for One Health.

Prof Goosen and the team are in the process of laying the groundwork for the establishment of a Kovsie One Health Research Unit, which will serve as a collaborative platform for research spanning human, animal, and environmental health. One of their key projects involves expanding TB and AMR surveillance in wildlife-livestock-human interfaces, using cutting-edge diagnostics and genomic tools. They are also initiating partnerships with industry and international institutions to address emerging zoonoses and environmental pathogens in a transdisciplinary manner.

News Archive

Counterfeit HIV / AIDS drugs must be dealt with
2006-02-16

Some of the guests attending the lecture were from the left Prof Johan Henning (Dean:  UFS Faculty of Law), Dr Jayasuriya, Prof Voet du Plessis (Head: UFS Department of Mercantile Law) and Dr Ezekiel Moraka (Vice-Rector:  Student Affairs at the UFS).
Photo: Stephen Collett

Counterfeit HIV / AIDS drugs must be dealt with

An international legal expert who has worked with various UN agencies has called on governments to deal quickly and decisively with people dealing in counterfeit HIV / AIDS drugs.

The Vice-President of the Global Jurists Foundation and former head of the UNAIDS secretariat in Pakistan, Dr Dayanath Jayasuriya, was speaking at the University of the Free State in Bloemfontein.

Delivering a guest lecture on HIV/ AIDS and human rights in developing countries, Dr Jayasuriya said counterfeit drugs were spreading at an alarming rate throughout the world.  He said that in particular counterfeit HIV / AIDS drugs contribute to the vulnerability of persons living with HIV / AIDS.

“Only a few countries have integrated anti-counterfeit drug provisions into national legislation on medicinal drugs” he said.
According to Dr Jayasuriya, the violation of the rights of people living with HIV / AIDS is continuing despite the fact that many governments have adopted various charters and declarations that are meant to guarantee the human rights of citizens.

He said these violations have included the brutal murder of persons with HIV / AIDS.

Other violations include verbal abuse and physical injuries through acts of torture; deprivation or denial of access to employment; medical facilities, including drugs; accommodation; food; social service benefits; insurance; custody of children, and so on.

“In recorded human history HIV / AIDS is by no means the first ever major public health epidemic to confront human kind. However, none of the other epidemics generated the same degree and intensity of human rights concerns,” Dr Jayasuriya said.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept